Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma. Blank CU, Lucas MW, Scolyer RA, van de Wiel BA, et al. N Engl J Med 2024 Jun 2. doi: 10.1056/NEJMoa2402604.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blank CU, Lucas MW, Scolyer RA, van de Wiel BA, et al. Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma. N Engl J Med 2024 Jun 2. doi: 10.1056/NEJMoa2402604.
PMID: 38828984